INGIBIROVANIE BIOSINTEZA KhOLESTERINA KAK TARGETNAYa TERAPIYa PRI SHH-OPOSREDOVANNYKh ONKOLOGIChESKIKh ZABOLEVANIYaKh
R E Muradimova , Z I Abramova
Medical academic journal ›› 2016, Vol. 16 ›› Issue (4) : 224 -225.
INGIBIROVANIE BIOSINTEZA KhOLESTERINA KAK TARGETNAYa TERAPIYa PRI SHH-OPOSREDOVANNYKh ONKOLOGIChESKIKh ZABOLEVANIYaKh
| [1] |
Rubin L. L., de Sauvage F. J. Targeting the Hedgehog pathway in cancer // Nature Reviews Drug Discovery.- 2006.- Vol. 12.- P. 1026-1033. |
| [2] |
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma / Packer R. J., Gajjar A. J., Vezina G., Rorke-Adams L., Burger P. C., Robertson P. L. et al. // Journal of Clinical Oncology.- 2006.- Vol. 24.- P. 4202-4208. |
| [3] |
Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells / Yang Z. J., Ellis T., Markant S. L., Read T. A., Kessler J. D., Bourboulas M., et al. // Cancer Cell.- 2008.- Vol. 14.- P. 135-145. |
| [4] |
Subtypes of medulloblastoma have distinct developmental origins / Gibson P., Yong T., Robinson G., Thompson M. C., Currle D. S., Eden C., et al. // Nature.- 2010.- Vol. 468.- P. 1095-1099. |
| [5] |
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma / Mulhern R. K., Palmer S. L., Merchant T. E., Wallace D., Kocak M., Brouwers P., et al. // Journal of Clinical Oncology.- 2005.- Vol. 24.- P. 5511-5519. |
| [6] |
Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response / Myers В. R., Sever N., Chong Y. C., Kim J., Belani J. D., Ruchnovsky S., et al. // Developmental Cell.- 2013.- Vol. 26 - P. 347-356. |
Muradimova R.E., Abramova Z.I.
/
| 〈 |
|
〉 |
PDF
